Medical Cannabis: What UK Doctors need to know

Event Information

Share this event

Date and Time

Location

Location

Royal Society Of Medicine London

1 Wimpole Street

London

W1G 0RE

United Kingdom

View Map

Event description
This event is for medical professionals who want to gain a clearer, evidence-based understanding of medical cannabis in the UK.

About this Event

Medical cannabis was rescheduled on the 1st of November 2018 and made available under prescription for patients in the UK across several conditions. The change in legislation and high-profile media campaigns have seen a surge in patients engaging with their GPs about medical cannabis - what it can do and whether it could help them. But it has been widely reported that training and information shared with clinicians about cannabis-based medicine has been limited.

This event offers a lifeline for those medical professionals who want to gain a clearer, evidence-based understanding from senior clinicians with expertise in managing conditions and medical cannabis. It has been designed to help debunk myths and provide international perspectives on evidence, prescribing and the future of cannabis and what it could mean in practice.

We will enable attendees to leave feeling more confident on how to engage with their patients and with a greater understanding of medicinal cannabis as part of a comprehensive treatment pathway, including other conventional pharmaceutical drugs and treatments.

This meeting is in association with the RSM Pain Medicine Section. The event will be followed by a canape and drinks reception in the inspiring surroundings of the Royal Society of Medicine.

Event speakers will include:

Dr Peter Irving MA MD MRCP: Consultant Gastroenterologist, Guys and St Thomas Hospital London

Dr Irving is internationally known as an expert in inflammatory bowel disease (Crohns Disease and Ulcerative Colitis). He leads the inflammatory bowel disease service at Guys and St Thomas Hospital, London where he also runs a large research and clinical trial programme, he is the first author of a randomised-controlled trial investigating cannabinoids in IBD.

Dr Amir Englund: PhD Cannabinoid Psychopharmacology, Institute of Psychiatry, King's College London

Dr Englund has worked on several experimental human cannabinoid studies. His focus has been on exploring the cognitive, subjective and psychopathological effects of acute cannabinoid administrations. He has also been involved in clinical trials of CBD as a treatment for psychotic disorders. Dr Englund’s research was recently featured on the BBC2 Horizons programme ‘Cannabis: Miracle Medicine or Dangerous Drug?’

Professor Praveen Anand MD., M.R.C.P., F.R.C.P: Professor of Neurology, Imperial College London .

Professor Praveen Anand is Professor of Clinical Neurology and Honorary Consultant Neurologist at Imperial College London. His research focuses on pathophysiological and molecular mechanisms in human sensory neuropathies and chronic pain syndromes and he has studied medicinal cannabis for approximately 20 years. He runs an integrated tertiary referral clinic evaluating patients with treatment resistant neuropathic pain.

Dr Zeid Mohamedali (MD, PhD, FRCSC)Chief Medical Officer, Zenabis Global and Adult and Paediatric Urology, British Columbia

Dr. Mohamedali is an active consulting urological surgeon in British Columbia, Canada with over 20 years of experience in medical research and clinical practice specialising in pain management, oncology and urological diseases. His work includes research projects, clinical trials, education, and policy reviews for medical use of cannabis. He serves as the Chairman of the Board for the Journal of Cannabinoid Medicine and has over 8 years of prescribing Cannabis based medicines. Dr. Mohamedali has a large practice of patients with chronic pain, insomnia, anxiety and gastrointestinal disease. He is currently involved in cannabis research for sleep, PTSD, learning, memory, opioid reduction, and pelvic pain; he was also an investigator in a phase 4 clinical trial in narcotic and benzodiazepine reduction using cannabis.

Event schedule:

6:00 Registration and Networking

6:30 Welcome to Medical Cannabis, What UK Doctors Need To Know

6:40 Cannabis 101 – Dr Zeid Mohamedali

6:50 Medicinal Cannabinoids in Inflammatory Bowel Disease - Dr Peter Irving

7:10 Medicinal Cannabinoids in Psychiatric Disorders - Dr Amir Englund

7:30 Medicinal Cannabinoids for Pain - Professor Praveen Anand

7:50 Break

8:15 Pearls of Prescribing and Practical Cases - Dr Zeid Mohamedali

9:00 Q&A session and Introduction to Sapphire Medical Clinics - Dr Michael Platt and Dr Mikael Sodergren

9:20 Refreshments and Networking

Sapphire Medical Clinics

Sapphire Medical Clinics are the first clinics in the UK registered with the CQC which can offer access to medicinal cannabis for all conditions acknowledged to benefit from it. The team of clinicians are based in Harley Street, London and includes specialists in paediatric & adult neurology, palliative care, psychiatry, gastroenterology, acute general medicine and neuropathic pain. The team can replicate the multi-disciplinary approach championed by the MHRA and NHS England as the safe and proper way to consider medicinal cannabis prescriptions. The GMC, MHRA and NHS England guidelines provide the basis for the rigorous Standard Operating Procedures that the clinicians will adhere to. You can view them here.

Sapphire clinics will operate primarily on a second-opinion basis, whereby patients can be referred by their GP or Hospital Consultant using this link.

As part of our educational programme, this event will be CPD accredited.

To find out more visit: our website.

Date and Time

Location

Royal Society Of Medicine London

1 Wimpole Street

London

W1G 0RE

United Kingdom

View Map

Save This Event

Event Saved